Nanoparticle 'Booster' trial aims to supercharge cancer treatment
Disease control
Ongoing
This early-stage trial is testing whether injecting a nanoparticle called NBTXR3 directly into a tumor, then activating it with radiation, can make immunotherapy work better for people with advanced cancers. The study will enroll about 145 patients with various cancers that have …
Phase: PHASE1 • Sponsor: Nanobiotix • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC